Skip to main content

Decode Nearly Doubles Revenues in Q2

NEW YORK (GenomeWeb News) – Decode Genetics reported after the close of the market on Wednesday that its second-quarter revenues nearly doubled to $15 million from $7.6 million year over year.
The Reykjavik, Iceland-based biopharmaceutical and molecular diagnostics firm noted in a statement that it also has $15.1 million in deferred revenue that will be recognized over future reporting periods.
Decode’s net loss increased 13.6 percent to $18.4 million, or $.30 per share, from $16.2 million, or $.27 per share. The quarter includes $1.2 million in non-operating expense tied to a revaluation of the firm’s non-current auction rate security investments. Decode also had taken charges in each of the previous two quarters related to the auction-rate securities.
The company’s R&D spending was cut 44.8 percent to $8 million from $14.5 million year over year, while its SG&A expenses edged up 4.4 percent to $7.1 million from $6.8 million.
Decode finished the quarter with $23.7 million in cash, cash equivalents, and current investments.
“As we ramp up our sales efforts in diagnostics and deCODEme, our discovery engine is providing us with a steady stream of intellectual property and content for new tests that leverage the same product development infrastructure,” Kari Stefansson, CEO of Decode, said in a statement.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.